Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Crypto and stablecoin adoption, board roles in AI and ASC 740 disclosure requirements are topics in Weaver’s Accounting & SEC Update: Q3 2025 summary.
See how audits for digital asset companies are evolving in 2026, with new rules, higher scrutiny and rising expectations for leaders.
WebinarDuring this on-demand webinar, we discuss practical insights and updates on regulatory, accounting and reporting issues that help public companies stay ahead.
Explore Q2 2025 trends in Texas life sciences, from capital selectivity and pipeline constraints to market recovery and beyond.
Explore Q1 2025 trends in Texas life sciences, from capital concentration and clinical momentum to innovation and public market dynamics.
Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
PodcastBecca Bratcher shares how women are reshaping Bitcoin education and access in her new book 21 Women in Bitcoin. A fresh look at digital assets.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
Executive ResourceBoard members might consider how emerging trends, shifting geopolitical considerations and the regulatory landscape will affect their business.
Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.
Learn how HMRC's guidelines impact transfer pricing for life sciences and other multinationals and how to mitigate risks and ensure compliance.
